EML4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.773600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.149200E-01
Normal-vs-Stage2
5.061000E-01
Normal-vs-Stage3
2.897800E-01
Normal-vs-Stage4
7.331000E-01
Stage1-vs-Stage2
7.263600E-01
Stage1-vs-Stage3
3.102000E-01
Stage1-vs-Stage4
3.482400E-01
Stage2-vs-Stage3
1.131230E-01
Stage2-vs-Stage4
2.644800E-01
Stage3-vs-Stage4
5.138300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.748800E-01
Normal-vs-AfricanAmerican
4.858600E-01
Normal-vs-Asian
1.989780E-01
Caucasian-vs-AfricanAmerican
5.532000E-01
Caucasian-vs-Asian
9.912200E-01
AfricanAmerican-vs-Asian
6.403200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.828400E-01
Normal-vs-Female
4.741800E-01
Male-vs-Female
8.730800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.233200E-01
Normal-vs-Age(41-60Yrs)
2.333800E-01
Normal-vs-Age(61-80Yrs)
4.405600E-01
Normal-vs-Age(81-100Yrs)
4.747800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.117200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.064400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.403400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.029700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.485200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.632600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.815400E-01
Normal-vs-Daily Drinker
1.279370E-01
Normal-vs-Weekly Drinker
1.643210E-01
Normal-vs-Occasional Drinker
1.958840E-01
Normal-vs-Social Drinker
3.734400E-01
Non Drinker-vs-Daily Drinker
7.692200E-01
Non Drinker-vs-Weekly Drinker
4.910200E-01
Non Drinker-vs-Occasional Drinker
8.647800E-01
Non Drinker-vs-Social Drinker
2.282200E-01
Daily Drinker-vs-Weekly Drinker
6.851200E-01
Daily Drinker-vs-Occasional Drinker
6.871200E-01
Daily Drinker-vs-Social Drinker
4.017400E-01
Weekly Drinker-vs-Occasional Drinker
4.774000E-01
Weekly Drinker-vs-Social Drinker
7.863200E-01
Occasional Drinker-vs-Social Drinker
2.209000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.921400E-01
Normal-vs-Grade 2
1.256210E-02
Normal-vs-Grade 3
1.484340E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.929900E-02
Grade 1-vs-Grade 3
4.183700E-02
Grade 1-vs-Grade 4
1.921400E-01
Grade 2-vs-Grade 3
9.204200E-01
Grade 2-vs-Grade 4
1.256210E-02
Grade 3-vs-Grade 4
1.484340E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.728200E-01
Normal-vs-NonDiabetic
4.403800E-01
Diabetic-vs-NonDiabetic
6.215400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.628800E-01
Normal-vs-NoPancreatitis
4.408000E-01
Pancreatitis-vs-NoPancreatitis
2.833000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.547800E-01
Normal-vs-N1
5.053200E-01
N0-vs-N1
3.818600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.785600E-01
Normal-vs-TP53-NonMutant
6.347900E-02
TP53-Mutant-vs-TP53-NonMutant
2.801600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
